Daytime Systolic Ambulatory Blood Pressure With a Direct Switch Between Candesartan Monotherapy and the Fixed‐Dose Combination Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL‐1)

類似資料

• Daytime Systolic Ambulatory Blood Pressure With a Two‐Step Switch From Candesartan to Olmesartan Monotherapy and the Fixed‐Dose Combination of Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL‐2)
  著者:: Bramlage, Peter, 等
  出版事項: (2013)
• Efficacy of Olmesartan/Amlodipine Single‐Pill Combination on 24‐h Mean Systolic Blood Pressure Measured by Ambulatory Monitoring in Non‐Responders to Valsartan or Candesartan Monotherapy
  著者:: Woo‐Baek Chung, 等
  出版事項: (2025-01-01)
• A Titrate‐to‐Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed‐Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide
  著者:: Weir, Matthew R., 等
  出版事項: (2011)
• Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
  著者:: Bramlage, Peter, 等
  出版事項: (2010)
• Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
  著者:: Bramlage, Peter, 等
  出版事項: (2014)